Type 2 diabetes patients may benefit from reduced carbohydrate intake

Adults with type 2 diabetes on a low-carbohydrate diet may see benefits to their beta-cell function allowing them to better manage their disease and possibly discontinue medication, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Catalent details revenue downturn, staff cuts as it looks forward to a brighter 2024

Catalent’s latest SEC filings added detail to the magnitude of the manufacturer’s 2023 revenue downturn, headcount reductions and the impact of reduced demand on its

December 12, 2023

Unexciting Earnings Season

The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis companies. This update is our first since

May 18, 2024

Organigram Q3 Revenue Declines 17% Sequentially

Organigram Reports Third Quarter Fiscal 2023 Results Year-to-date Canadian recreational business grew 10% versus prior year driven by continued focus on consumer-centric products and brands

July 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.